![]() |
|
|
Vol. 289, Issue 3, 1611-1619, June 1999
Department of Pharmacology, New York Medical College, Valhalla, New
York
The corneal epithelium metabolizes arachidonic acid by a
cytochrome P-450 (CYP)-mediated activity to
12-hydroxy-5,8,11,14-eicosatetraenoic acid
(12(R)-HETE) and 12-hydroxy-5,8,14-eicosatrienoic acid
(12(R)-HETrE ). Both metabolites possess potent
inflammatory properties, with 12(R)-HETrE being a
powerful angiogenic factor, and they assume the role of inflammatory
mediators in hypoxia- and chemical-induced injury in the cornea in vivo
and in vitro. We used a model of corneal organ culture that exhibits
hypoxia-induced epithelial CYP-dependent 12(R)-HETE and
12(R)-HETrE synthesis for isolating, identifying, and
characterizing the CYP protein responsible for these eicosanoid
syntheses. Northern analysis revealed the presence of a
CYP4A-hybridizable mRNA, the levels of which were increased after
hypoxia. Reverse transcription-polymerase chain reaction analysis with primers specific for the CYP4A family led to the isolation of a 671-base pair fragment with a 98.8% sequence homology to the rabbit lung CYP4B1 isoform, of which the levels in the corneal
epithelium were greatly increased under hypoxic conditions. Moreover,
phenobarbital, an inducer of hepatic CYP4B1 in the rabbit, also induced
12-HETE and 12-HETrE synthesis. Antibodies against CYP4B1, but not
against CYP4A1, inhibited hypoxia-, clofibrate-, and
phenobarbital-induced 12-HETE and 12-HETrE synthesis. These results
suggest the involvement of a CYP4B1 isoform in the corneal epithelial
synthesis of these eicosanoids in response to hypoxia.